SCHEMBL9696802

SCHEMBL9696802

COP(=O)(C#Cc1c(-c2ccc(F)cc2)c2n(c1C(C)C)CCCC2)C[C@H](CC(=O)O)O[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9697110 0.88 KMT2A (0.31) KCNK3
SCHEMBL9780976 0.84 CYP2C9 (0.31)
SCHEMBL9655519 0.84 HMGCR (0.35)
SCHEMBL9695383 0.84 HMGCR (0.37)
SCHEMBL9696808 0.83
SCHEMBL9696814 0.83
SCHEMBL9441753 0.80 ALDH1A1 (0.32)
SCHEMBL8953003 0.80
SCHEMBL8952835 0.79
SCHEMBL8952940 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5124453-A Treatment of corresponding aldehyde with lithium bis(tri-methylsilyl)amide E. R. SQUIBB & SONS, INC. (US) 1992-06-23 US disclosed
EP-0444532-A1 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method E.R. SQUIBB & SONS, INC. (US) 1991-09-04 EP disclosed
US-5025000-A Anticholesterol, antilipemic agents E. R. SQUIBB & SONS, INC. (US) 1991-06-18 US disclosed